NCP Litigation Trust v. KPMG

945 A.2d 132, 399 N.J. Super. 606, 2007 N.J. Super. LEXIS 389
CourtNew Jersey Superior Court Appellate Division
DecidedJune 22, 2007
StatusPublished
Cited by6 cases

This text of 945 A.2d 132 (NCP Litigation Trust v. KPMG) is published on Counsel Stack Legal Research, covering New Jersey Superior Court Appellate Division primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
NCP Litigation Trust v. KPMG, 945 A.2d 132, 399 N.J. Super. 606, 2007 N.J. Super. LEXIS 389 (N.J. Ct. App. 2007).

Opinion

945 A.2d 132 (2007)
399 N.J. Super. 606

NCP LITIGATION TRUST, Plaintiff,
v.
KPMG, Defendant.

Superior Court of New Jersey, Law Division.

Decided June 22, 2007.

*135 Karen A. Denys, and Vincent Gentile, Princeton (Drinker, Biddle & Reath, LLP, attorneys) and Mitchell A. Karlan, New York, NY (Gibson, Dunn & Crutcher, LLP, attorneys) of the New York bar, admitted pro hac vice, for defendant.

Allyn Z. Lite, and Bruce Greenberg, Newark (Lite, DePalma, Greenberg & Rivas, LLP, attorneys) and James G. Flynn (Harwood Feffer, LLP, attorneys), of the New York bar, admitted pro hac vice, for plaintiff.

WINARD, J.S.C.

This action against defendant, KPMG LLP ("KPMG"), arises out of the demise of Physician Computer Network, Inc. ("PCN"), which once developed, marketed, and supported practice management software products for physicians. On December 7, 1999, after a series of disclosures about its accounting practices, which resulted in a spiraling cash flow deficit and default on its bank debt, PCN filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code. On May 9, 2002, plaintiff, NCP Litigation Trust (the "Trust"), the successor-in-interest to, inter alia, the claims of PCN against KPMG, filed suit against KPMG alleging that KPMG's breach of contract; negligence, negligent misrepresentation, and breach of fiduciary duty injured PCN.

After a long and protracted procedural history, which the court will detail below, only two claims remain against KPMG — negligence and negligent misrepresentation. KPMG now moves to 1) dismiss the complaint on the grounds that the Trust lacks standing because it cannot show that PCN has suffered an injury, and, in the alternative, 2) dismiss the Trust's claims as to KPMG's 1995 audit on the grounds that they are time-barred. The court disagrees on both grounds and, for the reasons stated below, denies KPMG's motion to dismiss in its entirety.

Background[1]

A. Mortell, Wraback, KPMG & the Fall of PCN

From mid-1993 until mid-1998, PCN, a publicly traded New Jersey corporation, retained KPMG, an international accounting firm, as its independent accounting and auditing firm. Throughout the term of the engagement, two PCN officers, John Mortell and Thomas Wraback, served as the primary liaisons between KPMG and PCN. John Mortell served as PCN's chief financial officer from 1992 to 1995, its chief operating officer from 1995 to 1997, and its president until 1998, when PCN's board of directors removed him from his position. Thomas Wraback served as PCN's controller from 1993 to 1995, its vice-president of finance from 1995 to 1996, and its senior vice-president and chief financial officer *136 until 1998, when PCN's board of directors terminated his employment.

During the mid-to-late 1990s, Mortell and Wraback engineered a plan to fraudulently inflate PCN's earnings and decrease its pliabilities. On April 1, 1996, PCN filed its annual report for the year ending December 31, 1995, on Form 10-K with the Securities and Exchange Commission (SEC). The 1995 Form 10-K reported that PCN earned revenues of almost $42 million for the year, a 104% increase from its reported revenues of $20.5 million in 1994, and a 584% increase from its reported revenues of $6 million in 1993. The inflated revenues effectively reduced PCN's net loss to $11 million, before extraordinary items. The 1995 financial statements were accompanied by an unqualified audit opinion by KPMG stating:

We have audited the consolidated financial statements of the Physician Computer Network, Inc. and subsidiaries as of December 31, 1995 and 1994, and the related consolidated statements of operations, changes in shareholders' equity (deficiency), and cash flows for each of the years in the three-year period ended December 31, 1995. These consolidated financial statements and financial statement schedule are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements and financial statement schedule based on our audits.
We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Physician Computer Network, Inc. and subsidiaries as of December 31, 1995 and 1994, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 1995, in conformity with generally accepted accounting principles. Also in our opinion, the related financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, and in all material respects, the information set forth therein.

The following day, April 2, 1996, PCN announced in a press release that it had filed a registration statement and prospectus with the SEC to offer seven million shares of PCN's common stock for sale to the public. On May 7, 1996, PCN filed an amended registration statement with the SEC, lowering the seven million share offering to 5.6 million shares. The registration statement and prospectus contained a copy of the corporation's audited financial statements for 1995 and KPMG's accompanying audit report, which was included with KPMG's express consent.

In 1997, PCN filed its annual report for 1996 with the SEC, which reported revenues of $96 million — more than double the revenues of the previous year. These revenues were fraudulently exaggerated by numerous sham transactions, including:

1) G. Barry Transaction. Near the end of fiscal year 1996, PCN entered into a $3.5 million bulk deal for software *137 licenses with G. Barry Associates ("G. Barry"). Notwithstanding G. Barry's inability to obtain financing when it entered into a reseller agreement with PCN in December 1996, Mortell asked G. Barry's president, Gerald T. Barry, to write a check to PCN in the amount of $3.5 million that was backdated to the end of December 1996. Gerald T. Barry agreed to do so, but only with the understanding that the check never be presented to the bank because there were insufficient funds to cover it. The check was never cashed. Nonetheless, Mortell and Wraback caused PCN to record a journal entry as of December 31, 1996, which increased revenue and cash by $3.5 million.
2) Equifax Liability. In January 1995, PCN entered into a marketing agreement with Equifax Healthcare EDI Services, Inc. ("Equifax") which granted Equifax the exclusive right to use electronic data that PCN was developing. In 1996, Equifax prepaid $4,791,290 to PCN. PCN promptly recorded a journal entry which (i) debited cash for $4,791,290 and (ii) credited a reserve account representing a liability to Equifax in the same amount, ostensibly representing the net present value of the monthly payments discounted at 11.5% per annum.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Coluccio, R. v. Karp, M.
Superior Court of Pennsylvania, 2015
Bondi v. Citigroup, Inc.
32 A.3d 1158 (New Jersey Superior Court App Division, 2011)
Forman v. Salzano (In Re Norvergence, Inc.)
405 B.R. 709 (D. New Jersey, 2009)
Thabault v. Chait Ex Rel. Estate of Chait
541 F.3d 512 (Third Circuit, 2008)
Thabault v. Chait
Third Circuit, 2008

Cite This Page — Counsel Stack

Bluebook (online)
945 A.2d 132, 399 N.J. Super. 606, 2007 N.J. Super. LEXIS 389, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ncp-litigation-trust-v-kpmg-njsuperctappdiv-2007.